zalutumumab - CISMeF

Preferred Label : zalutumumab;

MeSH note : directed against epidermal growth factor receptor for treatment of squamous cell cancer of head and neck;

MeSH hyponym : humax-EGFR, 2F8; humax-EGFR-2F8;

Is substance : O;

UNII : DA709Q5020;

Details

Origin ID

C546618;

UMLS CUI

C1831978;

Currated CISMeF NLP mapping
- Zalutumumab [NCIt concept]
MeSH term(s) associated for indexing
- antibodies, monoclonal [MeSH Descriptor]
- antibodies, monoclonal, humanized [MeSH Descriptor]
Pharmacological action(s)
- Antineoplastic Agents, Immunological [MeSH Descriptor]
Record concept(s)
- humax-EGFR [MeSH concept]
- zalutumumab [MeSH concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Zalutumumab [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients